: To investigate the effect of Eupalinolide B (EB) on amyotrophic lateral sclerosis (ALS). Method: EB was administered 20 mg/d orally
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: